Institution · Oragenics (United States)
Most cited papers from Oragenics (United States)
What are the most cited papers from Oragenics (United States)?
The most cited paper from Oragenics (United States) is "An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II" (Hester E. Hasper, Naomi E. Kramer, Leif Smith et al., 2006), with 504 citations. Next come "Aging: The Reality: Biomarkers of Aging: From Primitive Organisms to Humans" (209) and "Preliminary assessment of safety and effectiveness in humans of ProBiora3 ™, a probiotic mouthwash" (93).
Showing 37 of 37 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | An Alternative Bactericidal Mechanism of Action for Lantibiotic Peptides That Target Lipid II Hester E. Hasper, Naomi E. Kramer, Leif Smith et al. · Science | 15 Sep 2006 | 504 |
| 2 | Aging: The Reality: Biomarkers of Aging: From Primitive Organisms to Humans Robert N. Butler, Richard A. Sprott, Huber R. Warner et al. · The Journals of Gerontology Series A | Jun 2004 | 209 |
| 3 | Preliminary assessment of safety and effectiveness in humans of ProBiora3 ™, a probiotic mouthwash R.T. Zahradnik, I. Magnusson, Clay Walker et al. · Journal of Applied Microbiology | 30 Mar 2009 | 93 |
| 4 | In vivo induced antigen technology (IVIAT) Sean M. Rollins, Amanda Peppercorn, Long Hang et al. · Cellular Microbiology | 21 Dec 2004 | 87 |
| 5 | Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials J.D. Hillman, Jong-Suk Mo, Emily McDonell et al. · Journal of Applied Microbiology | 10 Apr 2007 | 79 |
| 6 | Identification of In Vivo-Induced Bacterial Protein Antigens during Human Infection with Salmonella enterica Serovar Typhi Jason B. Harris, Andrea Baresch-Bernal, Sean M. Rollins et al. · Infection and Immunity | 22 Aug 2006 | 77 |
| 7 | Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics Leif Smith, J.D. Hillman · Current Opinion in Microbiology | Oct 2008 | 75 |
| 8 | Patient Persistency with ocular prostaglandin therapy: A population-based, retrospective study Gregory Reardon, Gail F. Schwartz, Essy Mozaffari · Clinical Therapeutics | Apr 2003 | 68 |
| 9 | Pharmacodynamic activity of the lantibiotic MU1140 Oliver G. Ghobrial, Hartmut Derendorf, Jeffery D. Hillman · International Journal of Antimicrobial Agents | 3 Oct 2008 | 61 |
| 10 | Pharmacokinetic and pharmacodynamic evaluation of the lantibiotic MU1140 Oliver G. Ghobrial, Hartmut Derendorf, Jeffrey D. Hillman · Journal of Pharmaceutical Sciences | 28 Dec 2009 | 53 |
| 11 | Site-Directed Mutations in the Lanthipeptide Mutacin 1140 Shaorong Chen, Shawanda Wilson-Stanford, William Cromwell et al. · Applied and Environmental Microbiology | 20 Apr 2013 | 51 |
| 12 | Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection Johan A. Kers, Robert E. Sharp, Anthony W. DeFusco et al. · Frontiers in Microbiology | 16 Mar 2018 | 50 |
| 13 | Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140 Rudramani Pokhrel, Nisha Bhattarai, Prabin Baral et al. · Physical Chemistry Chemical Physics | 2019 | 45 |
| 14 | Identification ofTannerella forsythiaantigens specifically expressed in patients with periodontal disease Ji Yeon Yoo, Hyeong Chan Kim, Weidong Zhu et al. · FEMS Microbiology Letters | 17 Sep 2007 | 33 |
| 15 | Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters Felicity C. Stark, Bassel Akache, Lise Deschatelets et al. · Scientific Reports | 13 Jun 2022 | 32 |
| 16 | A spontaneous lactate dehydrogenase deficient mutant ofStreptococcus rattusfor use as a probiotic in the prevention of dental caries J.D. Hillman, Emily McDonell, T. Cramm et al. · Journal of Applied Microbiology | 24 Apr 2009 | 32 |
| 17 | Application of In Vivo Induced Antigen Technology (IVIAT) to Bacillus anthracis Sean M. Rollins, Amanda Peppercorn, John S. Young et al. · PLoS ONE | 18 Mar 2008 | 27 |
| 18 | Human serum binding and its effect on the pharmacodynamics of the lantibiotic MU1140 Oliver G. Ghobrial, Hartmut Derendorf, Jeffrey D. Hillman · European Journal of Pharmaceutical Sciences | 24 Sep 2010 | 24 |
| 19 | OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections Johan A. Kers, Anthony W. DeFusco, Jae H. Park et al. · PLoS ONE | 12 Jun 2018 | 22 |
| 20 | Identification of Leishmania Proteins Preferentially Released in Infected Cells Using Change Mediated Antigen Technology (CMAT) Peter E. Kima, J. Alfredo Bonilla, Eumin Cho et al. · PLoS neglected tropical diseases | 5 Oct 2010 | 18 |
| 21 | Prevalence of Atrial Fibrillation in US Nursing Homes: Results from the National Nursing Home Survey, 1985–2004 Gregory Reardon, Winnie W. Nelson, Aarti A. Patel et al. · Journal of the American Medical Directors Association | 9 May 2012 | 18 |
| 22 | Identification of genes expressed in cultures of E. coli lysogens carrying the Shiga toxin-encoding prophage Φ24B Laura M. Riley, Marta Veses-Garcia, Jeffrey D. Hillman et al. · BMC Microbiology | 22 Mar 2012 | 17 |
| 23 | Warfarin for Prevention of Thrombosis Among Long-Term Care Residents with Atrial Fibrillation: Evidence of Continuing Low Use Despite Consideration of Stroke and Bleeding Risk Gregory Reardon, Winnie W. Nelson, Aarti A. Patel et al. · Drugs & Aging | 2 Mar 2013 | 16 |
| 24 | Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of Clostridium difficile -Associated Infection Mark Pulse, Jason Weiss, Johan A. Kers et al. · Antimicrobial Agents and Chemotherapy | 18 Jan 2019 | 15 |
| 25 | Blueprints for the rational design of therapeutic mutacin 1140 variants Johan A. Kers, Robert E. Sharp, Sheela Muley et al. · Chemical Biology & Drug Design | 16 Jul 2018 | 13 |
| 26 | Lipid II Binding and Transmembrane Properties of Various Antimicrobial Lanthipeptides Rudramani Pokhrel, Nisha Bhattarai, Prabin Baral et al. · Journal of Chemical Theory and Computation | 7 Dec 2021 | 12 |
| 27 | Development and validation of a LC–MS quantification method for the lantibiotic MU1140 in rat plasma Oliver G. Ghobrial, Hartmut Derendorf, Jeffrey D. Hillman · Journal of Pharmaceutical and Biomedical Analysis | 25 Dec 2008 | 12 |
| 28 | Use of Warfarin Therapy Among Residents Who Developed Venous Thromboembolism in the Nursing Home Gregory Reardon, Naushira Pandya, Edith A. Nutescu et al. · The American journal of geriatric pharmacotherapy | Dec 2012 | 11 |
| 29 | Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules Neelimmathara V. Rajeshkumar, Johan A. Kers, Scott Moncrief et al. · Toxicology and Applied Pharmacology | 26 Apr 2019 | 9 |
| 30 | Initial Clarification by Aqueous Two-Phase Partitioning of Leaf Extracts from Solanum tuberosum Plants Expressing Recombinant Therapeutic Proteins Keith Miller, Brian S. Hooker, Johnway Gao et al. · BioProcessing Journal | 30 Apr 2004 | 7 |
| 31 | Complete synthesis of the bicyclic ring of a mutacin analog with orthogonally protected lanthionine via solid‐phase intracyclization Kostyantyn Kirichenko, Jeffrey D. Hillman, Martin Handfield et al. · Journal of Peptide Science | Nov 2019 | 6 |
| 32 | Dental whitening effect of an oral probiotic Jeffrey D. Hillman, Emily McDonell, Charles H. Hillman et al. · Dental Oral and Craniofacial Research | 2016 | 6 |
| 33 | Factors Associated With Persistent Symptoms Following Mild Traumatic Brain Injury W. Frank Peacock, Damon Kuehl, Ramon R. Diaz-Arrastia et al. · JAMA Network Open | 17 Oct 2025 | 4 |
| 34 | Intranasal Immunization with a Proteosome-Adjuvanted SARS-CoV2 Spike Protein-Based Vaccine is Immunogenic and Efficacious in Mice & Hamsters Felicity C. Stark, Bassel Akache, Lise Deschatelets et al. · bioRxiv (Cold Spring Harbor Laboratory) | 2 Mar 2022 | 1 |
| 35 | The Prevalence and Recognition of Chronic Kidney Disease and Anemia in Long-Term Care Residents Gregory Reardon, Michael R. Wasserman, R. Scott McKenzie et al. · The Consultant Pharmacist | Sep 2012 | 1 |
| 36 | Chip-to-World Interfaces for High-Throughput Lab-on-a-Chip Devices Sebastian Böhm, T.T. Veenstra, Albert van den Berg et al. | 2002 | 1 |
| 37 | Proteomics-based expression library screening – a platform technology for rapid discovery of pathogen-specific markers of infection Indira T. Kudva, Stephen B. Calderwood, Manohar John · Expert Opinion on Medical Diagnostics | Aug 2008 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.